Cargando…
Novel FGFR2-INA fusion identified in two low-grade mixed neuronal-glial tumors drives oncogenesis via MAPK and PI3K/mTOR pathway activation
Autores principales: | Jain, Payal, Surrey, Lea F., Straka, Joshua, Luo, Minjie, Lin, Fumin, Harding, Brian, Resnick, Adam C., Storm, Phillip B., Buccoliero, Anna Maria, Santi, Mariarita, Li, Marilyn M., Waanders, Angela J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015095/ https://www.ncbi.nlm.nih.gov/pubmed/29767381 http://dx.doi.org/10.1007/s00401-018-1864-5 |
Ejemplares similares
-
Discovery and functional characterization of the oncogenicity and targetability of a novel NOTCH1–ROS1 gene fusion in pediatric angiosarcoma
por: Jain, Payal, et al.
Publicado: (2022) -
Adult Neurogenesis and Glial Oncogenesis: When the Process Fails
por: Batista, Chary Marquez, et al.
Publicado: (2014) -
The Oncogenesis of Glial Cells in Diffuse Gliomas and Clinical Opportunities
por: Zhuang, Qiyuan, et al.
Publicado: (2022) -
Overcoming resistance to single-agent therapy for oncogenic BRAF gene fusions via combinatorial targeting of MAPK and PI3K/mTOR signaling pathways
por: Jain, Payal, et al.
Publicado: (2017) -
NTRK Fusions Identified in Pediatric Tumors: The Frequency, Fusion
Partners, and Clinical Outcome
por: Zhao, Xiaonan, et al.
Publicado: (2021)